Skip navigation

Treatment of neurodegenerative conditions

Treatment of neurodegenerative conditions

BTG International Ltd. (2011) Treatment of neurodegenerative conditions. JP2011144195.

Full text not available from this repository.


To provide a method for treating a patient in need of therapy for a neurodegenerative disease.

SOLUTION: The method includes administering a therapeutically effective dose of a triglyceride oil containing both [gamma]-linolenic acid and linoleic acid residues as triglyceride ester, wherein the ratio of [gamma]-linolenic acid to linoleic acid residues at the sn-2 position of the triglyceride is at least 0.8; the amount of [gamma] -linolenic acid residues at the sn-2 position is at least 18%, wherein the oil is administered at a dose sufficient to maintain or elevate TGF-[beta]1 levels in the patient at a therapeutic level. Preferred oils are Borage or Mucor oils having at least 35% of the sn-2 position fatty acid residues as [gamma]-linolenic acid.

Item Type: Patent
Uncontrolled Keywords: multiple sclerosis, neurodegeneration, central nervous system
Subjects: R Medicine > R Medicine (General)
Faculty / Department / Research Group: Faculty of Engineering & Science > Department of Life & Sports Sciences
Last Modified: 05 Dec 2016 11:42
Selected for GREAT 2016: None
Selected for GREAT 2017: None
Selected for GREAT 2018: None
Selected for GREAT 2019: None

Actions (login required)

View Item View Item